Although ICG was approval by FDA and clinically available for many decades, its non-targeting properties make it unable to precisely and selectively target certain tumors and tissues, which has limited its usage in many applications of intraoperative tumor detection. Precise and specific targeting of tumors by selective detection agents would be of high clinical value.